AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 5 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Recs

0
Player Avatar RetiredAt37 (54.39) Submitted: 4/29/2011 8:59:01 AM : Outperform Start Price: $46.74 AZN Score: -8.80

Value play. The outlook for the company is not as bad as many think.

Featured Broker Partners


Advertisement